Here's Why Neuronetics (STIM) is Poised for a Turnaround After Losing 37.8% in 4 WeeksZacks Investment Research • Thursday
Neuronetics (STIM) Loses 34.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • Tuesday
Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common StockGlobeNewsWire • 11/11/26
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference CallGlobeNewsWire • 10/21/26
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR SystemGlobeNewsWire • 09/08/26
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, MarylandGlobeNewsWire • 07/28/26
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference CallGlobeNewsWire • 07/28/26
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management ChangesGlobeNewsWire • 07/20/26
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026GlobeNewsWire • 07/06/26
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS TreatmentGlobeNewsWire • 05/14/26